Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China
· Delayed Price · Currency is CNY 32.81
-0.91 (-2.70%)
Mar 9, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 10.37 billion as of March 9, 2026. Its market cap has decreased by -5.24% in one year.
Market Cap
10.37B
Enterprise Value
11.90B
Revenue
1.94B
Ranking
n/a
PE Ratio
31.55
Stock Price
32.81
Market Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 10.37B, a decrease of -37.24%. That is a compound annual growth rate of -9.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.66B | -10.56% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| HitGen | 10.83B |
| Chengzhi | 10.85B |
| Aurisco Pharmaceutical | 10.37B |
| Liaoning Chengda Biotechnology | 10.25B |
| Chongqing Genrix Biopharmaceutical | 9.84B |
| Hualan Biological Vaccine | 11.55B |
| Chengdu Olymvax Biopharmaceuticals | 11.58B |